This information was published on 2025-10-23T03:11:11 for IP Right Filed Published.
| Field | Value |
| (210) | 2597071 (IR 1882579) |
| (220) |
08 May 2025
|
| (300) |
US, 08 Nov 2024, 98844592
|
| (511) (510) |
Class 5
Medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and set for administering lipid emulsion to patients for medical purposes (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations), all for use in treating anesthetic and drug toxicity; medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and set for administering lipid emulsion to patients for medical purposes (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations) (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations), all for use in resuscitating patients; medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and set for administering lipid emulsion to patients for medical purposes (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations), all for use in treating cardiac arrest due to ischemia and cardiac failure; syringes that are used for administering lipid emulsions in the nature of syringes sold filled with a pharmaceutical, namely, a lipid emulsion for use in treating anesthetic and drug toxicity, treating neurological toxicity, treating cardiac arrest due to ischemia, treating cardiac failure, treating cardiac toxicity, and for resuscitating patients. Class 10 An empty medical syringe. |
| (540) | RESQ PHARMA |
| (550) | Word |
| (730) |
ResQ Pharma, Inc.
|
Find out more about publications on the About page.